This relevance of PD-1 signaling in tumor immunity is exemplified by the identification of PD-1 expression in CD8+ T cells as a biomarker of resident tumor reactive T cell subpopulations in advanced melanoma and cervical cancer patients [55,56]. Here, PDCD1 is linked to cervical cancer.